Christopher B. McClain
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Liver Disease and Transplantation
-
- Immunotherapy and Immune Responses
Papers in
-
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 2
-
- Pluripotent Stem Cells Research 1
- Co-authors
- Anna Mae Diehl (2 shared papers)S. Q. Yang (1 shared paper)Sally Nelson (1 shared paper)Paul Akerman (1 shared paper)G. J. Bagby (1 shared paper)Nina Bhardwaj (4 shared papers)Christopher L. Karp (1 shared paper)Shiqi Yang (1 shared paper)
- Journals
- Cancer Immunology Research (2 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (2 papers)Molecular Cancer Therapeutics (1 paper)Hepatology (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Christopher B. McClain
9 papers receiving 700 citations
Peers
Comparison fields: 5 of 70
- Hepatology 286
- Immunology 186
- Oncology 164
- Epidemiology 192
- Pharmacology 49
Countries citing papers authored by Christopher B. McClain
This map shows the geographic impact of Christopher B. McClain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. McClain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. McClain more than expected).
Fields of papers citing papers by Christopher B. McClain
This network shows the impact of papers produced by Christopher B. McClain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. McClain. The network helps show where Christopher B. McClain may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher B. McClain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 356 | |
| 2 | 2020 | 131 | |
| 3 | 1996 | 102 | |
| 4 | 2019 | 60 | |
| 5 | 2021 | 47 | |
| 6 | 2018 | 16 | |
| 7 | 1993 | 2 | |
| 8 | 2025 | 1 | |
| 9 | 2018 | 1 |
About Christopher B. McClain
Christopher B. McClain is a scholar working on Immunology, Molecular Biology, Cancer Research, Surgery and Oncology, having authored 9 papers that have together received 716 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Liver physiology and pathology (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers), Organ Transplantation Techniques and Outcomes (2 papers), Cancer Genomics and Diagnostics (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Hepatology (286 citations), Immunology (186 citations), Oncology (164 citations), Epidemiology (192 citations) and Pharmacology (49 citations). Christopher B. McClain has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Anna Mae Diehl, S. Q. Yang, Sally Nelson, Paul Akerman, G. J. Bagby, Nina Bhardwaj, Christopher L. Karp, Shiqi Yang, Andrew S. Klein and Theofano Orfanelli. Their work appears in journals such as Cancer Immunology Research, American Journal of Physiology-Gastrointestinal and Liver Physiology, Molecular Cancer Therapeutics, Hepatology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.